Cargando…
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety
Autores principales: | Perry, MEO, Almaani, N, Desai, N, Fox, J, Larbalestier, N, Chilton, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112885/ http://dx.doi.org/10.1186/1758-2652-13-S4-P110 |
Ejemplares similares
-
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinco-histopathologic studies of 45 cases
por: Skowron, Francois, et al.
Publicado: (2014) -
Clinical pattern of liver injury in drug reaction with eosinophilia and systemic symptoms (DRESS): a retrospective study in Taiwan
por: Chen, Kai-Lung, et al.
Publicado: (2014) -
Immune reconstitution inflammatory syndrome observed in the setting of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS)
por: Kano, Yoko, et al.
Publicado: (2014) -
High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
por: Pena, N Mantovani, et al.
Publicado: (2010) -
PD33 - Drug Reaction and Eosinophilia with Systemic Symptoms (DRESS): a 10-year review in a pediatric population
por: Wong, Sharon, et al.
Publicado: (2014)